Back to search

Article

A Patient-Derived Tumoroid Platform for NF1 Low-Grade Glioma shows Myeloid Evolution and Shifting Metabolic Dependencies in vitro

2026-03-25

Abstract excerpt

<title>Abstract</title> <p> About 10–15% of individuals with Neurofibromatosis Type 1 develop a low-grade glioma (LGG) within the optic pathway, and an additional 3–5% of individuals develop LGG outside of the optic pathway. In recent years molecular analysis has greatly enhanced our understanding of what drives these NF1 LGG; however, to date <italic>in vitro</italic> and <italic>in vivo</italic> models are...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
35fb2871-ace9-52be-a172-c85d1593804a
DOI
10.21203/rs.3.rs-9118779/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Patient-Derived Tumoroid Platform for NF1 Low-Grade Glioma shows Myeloid Evolution and Shifting Metabolic Dependencies in vitroDOI 10.21203/rs.3.rs-9118779/v1
Select a neighboring publication to make it the new centre.